
The Centers for Medicare & Medicaid Services (CMS) issued a Request for Information (RFI) to inform new federal standards for “reasonable and relevant” contract terms between Medicare Part D plans and network pharmacies.
Part D plans are currently required to contract with any pharmacy that meets their standard terms and conditions, but CMS has not established additional requirements defining what constitutes reasonable and relevant terms.
Federal law now requires HHS to establish these standards by April 2028 for plan years beginning in 2029. CMS seeks feedback on pharmacy reimbursement and dispensing fees, contracting practices, pharmacy quality measures, audits, access to medications, and other issues, including how these practices affect rural and other underserved areas.
CMS also specifically requests information about Part D contract terms for dispensing drugs to Medicare beneficiaries who receive drugs through the 340B Drug Pricing Program and whether reimbursement rates are related to “pharmacy deserts” in rural and other underserved areas.
Comment by November 23.